Progress on ocular siRNA gene-silencing therapy and drug delivery systems

被引：36
|
作者：
Jiang, Jinjin [1 ,2 ]
Zhang, Xinru [1 ,2 ]
Tang, Yue [1 ,2 ]
Li, Shuhan [2 ]
Chen, Jing [2 ]
机构：
[1] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, 1 DongQing Rd, Guiyang 550014, Peoples R China
[2] China Pharmaceut Univ, Dept Pharm, 639 Longmian Ave, Nanjing 211198, Peoples R China
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2021年 / 35卷 / 01期
关键词：
age-related macular degeneration; glaucoma; RNA interference technology; siRNA drugs; non-viral vectors; ENDOTHELIAL GROWTH-FACTOR; BETA-ADRENERGIC RECEPTORS; VEGF SIRNA; POSTERIOR SEGMENT; POLYETHYLENIMINE NANOPARTICLES; INTRAVITREAL INJECTION; MACULAR DEGENERATION; NONVIRAL VECTORS; RNA INTERFERENCE; CLINICAL-TRIAL;
D O I：
10.1111/fcp.12561
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Age-related macular degeneration (AMD) and glaucoma are global ocular diseases with high blindness rate. RNA interference (RNAi) is being increasingly used in the treatment of these disorders with siRNA drugs, bevasiranib, AGN211745 and PF-04523655 for AMD, and SYL040012 and QPI-1007 for glaucoma. Administration routes and vectors of gene drugs affect their therapeutic effect. Compared with the non-viral vectors, viral vectors have limited payload capacity and potential immunogenicity. This review summarizes the progress of the ocular siRNA gene-silencing therapy by focusing on siRNA drugs for AMD and glaucoma already used in clinical research, the main routes of drug delivery and the non-viral vectors for siRNA drugs.
引用
收藏
页码：4 / 24
页数：21
相关论文
共 50 条
  • [21] Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery
    Bhattacharjee, Arpita
    Das, Pranab J.
    Adhikari, Piya
    Marbaniang, Daphisha
    Pal, Paulami
    Ray, Subhabrata
    Mazumder, Bhaskar
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (01) : 113 - 126
  • [22] Design of bifunctional siRNAs: Combining immunostimulation and gene-silencing in one single siRNA molecule
    Furset, Gro
    Sioud, Mouldy
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 352 (03) : 642 - 649
  • [23] Dendrimers as Carriers for siRNA Delivery and Gene Silencing: A Review
    Wu, Jiangyu
    Huang, Weizhe
    He, Ziying
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [24] Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing
    Tambe, Vishakha
    Thakkar, Shreya
    Raval, Nidhi
    Sharma, Dilip
    Kalia, Kiran
    Tekade, Rakesh K.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (20) : 2952 - 2975
  • [25] Efficient siRNA delivery and effective gene silencing by lipoplexes
    Metwally, Abdelkader A.
    Pourzand, Charareh
    Blagbrough, Ian S.
    DRUG DISCOVERY TODAY, 2010, 15 (23-24) : 1090 - 1090
  • [26] Progress ion RNA interference - Gene-silencing advances create industry buzz
    Liszewski, K
    GENETIC ENGINEERING NEWS, 2003, 23 (11): : 1 - +
  • [27] Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects
    Tahara, Kohei
    Yamamoto, Hiromitsu
    Hirashima, Naohide
    Kawashima, Yoshiaki
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 74 (03) : 421 - 426
  • [28] Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications
    Rujitanaroj, Pim-on
    Wang, Yu-Cai
    Wang, Jun
    Chew, Sing Yian
    BIOMATERIALS, 2011, 32 (25) : 5915 - 5923
  • [29] Progress in transdermal drug delivery systems for cancer therapy
    Tianyue Jiang
    Guo Xu
    Guojun Chen
    Yu Zheng
    Bingfang He
    Zhen Gu
    Nano Research, 2020, 13 : 1810 - 1824
  • [30] Impact of siRNA Overhangs for Dendrimer-Mediated siRNA Delivery and Gene Silencing
    Posocco, Paola
    Liu, Xiaoxuan
    Laurini, Erik
    Marson, Domenico
    Chen, Chao
    Liu, Cheng
    Fermeglia, Maurizio
    Rocchi, Palma
    Pricl, Sabrina
    Peng, Ling
    MOLECULAR PHARMACEUTICS, 2013, 10 (08) : 3262 - 3273
12345